Among these genes, the two most frequently cited genes were TP53 (1837 overall; 49 citations revealing as a tumour suppressor (35), driver (9), and oncogene (5) in PCa) and MET (417 overall; 4 citations playing as an oncogene in PCa) (Additional file 2: Table S2). The gene discussed is TP53; the disease is posterior cortical atrophy.